About Mouad Edderkaoui
Form D filings for Avenzoar Pharmaceuticals from 2019 to 2023 list Mouad Edderkaoui as director.
Mouad Edderkaoui first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Mouad Edderkaoui in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mouad Edderkaoui works with at each company, as listed on that company's latest Form D.
Avenzoar Pharmaceuticals, Inc. · Form D, Jun 16, 2023
MC
Mark Chin
Director
SW
Shierley Widjaja
Director
SP
Stephen Pandol
Director
TB
Terrance Bruggeman
Chief Executive Officer and director